Qiagen N.V.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
20.10%
Market Cap
6.44 Bil.
P/E Ratio
23.17
Dividend Yield
0.00 %
Earnings per Share
1.81 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
| ResMed Inc. | 32.17 Bil. | 4.73 Bil. | 27.14 | +36.48 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 31.25 G | 0 Units |
| PRICE DETERMINATION TIME | 06/08/2026 / 09:55:32 PM | |
| DAILY VOLUME (UNITS) | 2,810 | |
| DAILY HIGH / LOW | 32.035 | 31.25 |
| PREV. DAY'S PRICE | 31.72 | (06/05) |
| CHANGE DAY BEFORE | -0.47 | -1.48 % |
| 52 WEEK HIGH / LOW | 48.995 (01/20) | 27.61 (05/12) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 2.26 | 2.10 | 1.81 | 0.37 | 1.53 |
| DIVIDENDS PER SHARE | 0.23 | 0.22 | 0.21(e) | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | - | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 14.39 | 15.46 | 23.17 | 119.72 | 29.35 |
| PRICE - BOOK RATIO | - | - | 2.58 | 2.77 | 2.66 |
| PRICE - SALES RATIO | - | - | 4.71 | 5.06 | 5.10 |
| PRICE - CASH FLOW RATIO | - | - | 15.04 | 14.86 | 21.80 |
Master Data
| WKN | A41HBE |
| ISIN | NL0015002SN0 |
| SYMBOL | QIA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Qiagen |
| INDEX MEMBERSHIP | DAX, TecDAX |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 206.08 Mil. |
| MARKET CAPITALISATION | 6.44 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.73 % | 9.02 % | -20.43 % | -21.11 % | -20.10 % | -27.86 % | -19.79 % | -18.22 % |
| HIGH | 32.66 | 32.66 | 40.36 | 49.00 | 49.00 | 49.00 | 53.07 | 49.00 |
| LOW | 30.41 | 27.61 | 27.61 | 27.61 | 27.61 | 27.61 | 27.61 | 27.61 |
Dividend
per share
Company profile
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
Structured products for Qiagen N.V.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.